Loading…
Loading…
MHUA (Meihua International Medical Technologies Co., Ltd.) is no longer actively trading.
This usually means the company was acquired and taken private, delisted from its exchange, or its ticker has been retired. Every price, valuation, dividend, and analyst figure on this page is frozen at the last available trading session and reads as historical reference — not a current-day signal.
MHUA does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for MHUA and 80,000+ other tickers.
See exactly how MHUA's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for MHUA and 80,000+ other tickers.
Meihua International Medical Technologies Co., Ltd. (MHUA) is a Chinese enterprise dedicated to the production and commercialization of medical consumables. The company offers a diverse range of single-use medical devices, categorized under Class I, II, and III. Its product portfolio encompasses non-bottled items like brushes and patient identification bracelets, as well as polyethylene bottled solutions such as containers for eye drops and tablets. Beyond its own manufacturing efforts, Meihua also serves as a distributor, supplying disposable medical equipment from other manufacturers to its…
Shares of Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA - Get Free Report) traded down 55.4% during mid-day trading on Friday. The stock traded as low as $7.36 and last traded at $6.25. 153,423 shares were traded during mid-day trading, an increase of 645% from the average session volume of 20,602 shares. The stock
U.S. stock futures were mixed this morning, with the Dow futures falling around 0.1% on Monday.
U.S. stock futures higher, Toll Brothers, Phreesia, Meihua Intl, Ooma, and Compass Minerals expected to report earnings.
Yangzhou, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Meihua International Medical Technologies Co., Ltd. (“Meihua” or the "Company") (Nasdaq: MHUA), a reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, announced today that the Company received a letter from the Nasdaq Stock Market LLC (“Nasdaq”) on December 2, 2025, notifying the Company that the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the “Delisting Determination”), because the Company failed to regain compliance with the Nasdaq Listing Rule 5550(a)(2) (the “Rule”).
YANGZHOU, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Meihua International Medical Technologies Co., Ltd. (“Meihua” or the “Company”) (Nasdaq: MHUA), reputable manufacturer and provider of Class I, II, and III disposable medical devices with operating subsidiaries in China, today announced that it would effectuate a reverse share split of its outstanding ordinary shares, par value of $0.0005 per share, at a ratio of 1-for-100, and implement its dual-class share structure, to be effective at the open of business on Monday, November 24, 2025.